SCHEMBL4444745

SCHEMBL4444745

[CH2]c1ccccc1-c1ccc(O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.56
ABCB1 P08183 2/20 0.56
BCR P11274 2/20 0.56
ESR2 Q92731 5/20 0.50
BCL2L1 Q07817 2/20 0.50
MMP3 P08254 1/20 0.50
ESR1 P03372 6/20 0.46
ALOX5 P09917 1/20 0.41
PTPN1 P18031 1/20 0.41
BACE1 P56817 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
RPS6KA3 P51812 2/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
GLA P06280 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8416898 0.87 ALDH1A1 (0.38) ABL1ABCB1BCRESR2BCL2L1
SCHEMBL1649339 0.82 ABL1 (0.76) ABL1ABCB1BCRESR2BCL2L1
SCHEMBL4432976 0.82 ABL1 (0.76) ABL1ABCB1BCRESR2BCL2L1
SCHEMBL1885427 0.79 ABL1 (0.73) ABL1ABCB1BCRESR2BCL2L1
SCHEMBL95436 0.79 ALDH1A1 (0.48) BCL2L1ALOX5BACE1ALDH1A1HPGD
SCHEMBL27500515 0.79 ALDH1A1 (0.42) BCL2L1BACE1ALDH1A1HPGDHSD17B10
SCHEMBL1481968 0.77 ALDH1A1 (0.46) BCL2L1MMP3ALOX5BACE1ALDH1A1
SCHEMBL29926196 0.77 BCL2L1 (0.74) ABL1ABCB1BCRESR2BCL2L1
SCHEMBL27641143 0.77 ALDH1A1 (0.46) BCL2L1ALOX5BACE1ALDH1A1HPGD
Ethane SCHEMBL28019198 0.77 ABL1 (0.70) ABL1ABCB1BCRESR2BCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090156635-A1 BIARYLOXYMETHYLARENECARBOXYLIC ACIDS AS GLYCOGEN SYNTHASE ACTIVATORS GILLESPIE PAUL 2009-06-18 US disclosed
US-7524870-B2 Biaryloxymethylarenecarboxylic acids as glycogen synthase activators HOFFMANN-LA ROCHE INC. (US) 2009-04-28 US disclosed
US-20060122256-A1 Biaryloxymethylarenecarboxylic acids as glycogen synthase activators GILLESPIE PAUL 2006-06-08 US disclosed
US-20060003252-A1 Chemical amplification type silicone based positive photoresist composition TOKYO OHKA KOGYO CO., LTD. (JP) 2006-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156635-A1 BIARYLOXYMETHYLARENECARBOXYLIC ACIDS AS GLYCOGEN SYNTHASE ACTIVATORS GYS2, GYS1, GSK3A ABL1 4376/4885ABCB1 1315/4885BCR 4350/4885
US-20060122256-A1 Biaryloxymethylarenecarboxylic acids as glycogen synthase activators GYS2, GYS1, GSK3A ABL1 4376/4885ABCB1 1315/4885BCR 4350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.